Reduced circulating BMP9 and pBMP10 in hospitalized COVID‐19 patients

Similar to other causes of acute respiratory distress syndrome, coronavirus disease 2019 (COVID‐19) is characterized by the aberrant expression of vascular injury biomarkers. We present the first report that circulating plasma bone morphogenetic proteins (BMPs), BMP9 and pBMP10, involved in vascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunmore, Benjamin J., Upton, Paul D., Auckland, Kate, Samanta, Romit J., Lyons, Paul A., Smith, Kenneth G. C., Gräf, Stefan, Summers, Charlotte, Morrell, Nicholas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881210/
https://www.ncbi.nlm.nih.gov/pubmed/36721385
http://dx.doi.org/10.1002/pul2.12192
Descripción
Sumario:Similar to other causes of acute respiratory distress syndrome, coronavirus disease 2019 (COVID‐19) is characterized by the aberrant expression of vascular injury biomarkers. We present the first report that circulating plasma bone morphogenetic proteins (BMPs), BMP9 and pBMP10, involved in vascular protection, are reduced in hospitalized patients with COVID‐19.

Ejemplares similares